Travoprost
6 NDCs across 3 manufacturers|4 Generic,2 Brand
Travoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 16, 2001, and the first generic was approved Mar 1, 2013. In 2024, Medicare Part D spent $86 million on Travoprost across 498,000 claims for 123,000 beneficiaries.
Travoprost is available as 6 NDCs from 3 manufacturers (4 generic, 2 brand), with NADAC prices from $8.39 to $94.30 per ML — the most expensive product costs about 11× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
4G / 2B
Manufacturers
3
competing in market
Price Spread
$8.39 – $94.30
per ML
7d Activity
avg +2.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sandoz Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Prostaglandin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing TRAVOPROST
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRAVATAN Z 0.004% EYE DROP | $94.2984 per ML | -0.11% |
TRAVATAN Z 0.004% EYE DROP | $94.2313 per ML | 0.00% |
TRAVOPROST 0.004% EYE DROP | $9.7475 per ML | +4.45% |
TRAVOPROST 0.004% EYE DROP | $9.7475 per ML | +4.45% |
TRAVOPROST 0.004% EYE DROP | $8.3941 per ML | +1.62% |
TRAVOPROST 0.004% EYE DROP | $8.3941 per ML | +1.62% |
Frequently Asked Questions
What is Travoprost used to treat?
Travoprost is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
When did Travoprost become available as a generic?
FDA approved the first generic Travoprost (ANDA) on Mar 1, 2013.
How much does Medicare spend on Travoprost?
In 2024, Medicare Part D spent $86 million on Travoprost across 498,000 claims for 123,000 beneficiaries.
How many Travoprost products are on the market?
The Travoprost drug market contains 6 NDCs from 3 manufacturers — 4 generic and 2 brand products.
What is the price range for Travoprost?
NADAC reference prices for Travoprost range from $8.3941 to $94.2984 per ML — the most expensive product costs about 11× the cheapest.
Is generic Travoprost cheaper than brand?
The average generic NADAC for Travoprost is $9.0708 per ML, versus $94.2649 for brand-labeled products — brand versions average about 10× the generic price.
Which manufacturers make Travoprost?
3 manufacturers list Travoprost in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (2), Sagent Pharmaceuticals (2), Apotex Corp. (2).
How has the price of Travoprost changed recently?
Over the past 7 days, 4 Travoprost NDCs rose and 1 fell, with a market-wide average change of +2.0%.